chrX-71129433-C-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_005120.3(MED12):​c.3691+4C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000601 in 1,164,439 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000036 ( 0 hom., 2 hem., cov: 23)
Exomes 𝑓: 0.0000028 ( 0 hom. 3 hem. )

Consequence

MED12
NM_005120.3 splice_region, intron

Scores

2
Splicing: ADA: 0.0002359
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: -1.54

Publications

0 publications found
Variant links:
Genes affected
MED12 (HGNC:11957): (mediator complex subunit 12) The initiation of transcription is controlled in part by a large protein assembly known as the preinitiation complex. A component of this preinitiation complex is a 1.2 MDa protein aggregate called Mediator. This Mediator component binds with a CDK8 subcomplex which contains the protein encoded by this gene, mediator complex subunit 12 (MED12), along with MED13, CDK8 kinase, and cyclin C. The CDK8 subcomplex modulates Mediator-polymerase II interactions and thereby regulates transcription initiation and reinitation rates. The MED12 protein is essential for activating CDK8 kinase. Defects in this gene cause X-linked Opitz-Kaveggia syndrome, also known as FG syndrome, and Lujan-Fryns syndrome. [provided by RefSeq, Aug 2009]
MED12 Gene-Disease associations (from GenCC):
  • FG syndrome 1
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • MED12-related intellectual disability syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • X-linked intellectual disability with marfanoid habitus
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • blepharophimosis - intellectual disability syndrome, MKB type
    Inheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • cholestasis-pigmentary retinopathy-cleft palate syndrome
    Inheritance: XL Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BP6
Variant X-71129433-C-T is Benign according to our data. Variant chrX-71129433-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 408884. Variant chrX-71129433-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 408884. Variant chrX-71129433-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 408884. Variant chrX-71129433-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 408884. Variant chrX-71129433-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 408884. Variant chrX-71129433-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 408884. Variant chrX-71129433-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 408884. Variant chrX-71129433-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 408884. Variant chrX-71129433-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 408884. Variant chrX-71129433-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 408884. Variant chrX-71129433-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 408884. Variant chrX-71129433-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 408884. Variant chrX-71129433-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 408884. Variant chrX-71129433-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 408884.
BS2
High Hemizygotes in GnomAd4 at 2 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MED12NM_005120.3 linkc.3691+4C>T splice_region_variant, intron_variant Intron 26 of 44 ENST00000374080.8 NP_005111.2 Q93074-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MED12ENST00000374080.8 linkc.3691+4C>T splice_region_variant, intron_variant Intron 26 of 44 1 NM_005120.3 ENSP00000363193.3 Q93074-1

Frequencies

GnomAD3 genomes
AF:
0.0000358
AC:
4
AN:
111705
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0000652
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000376
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00000558
AC:
1
AN:
179086
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.0000816
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000285
AC:
3
AN:
1052734
Hom.:
0
Cov.:
28
AF XY:
0.00000928
AC XY:
3
AN XY:
323192
show subpopulations
African (AFR)
AF:
0.0000391
AC:
1
AN:
25608
American (AMR)
AF:
0.00
AC:
0
AN:
35070
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19101
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30004
South Asian (SAS)
AF:
0.00
AC:
0
AN:
52949
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40429
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4023
European-Non Finnish (NFE)
AF:
0.00000250
AC:
2
AN:
800924
Other (OTH)
AF:
0.00
AC:
0
AN:
44626

Age Distribution

Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000358
AC:
4
AN:
111705
Hom.:
0
Cov.:
23
AF XY:
0.0000590
AC XY:
2
AN XY:
33909
show subpopulations
African (AFR)
AF:
0.0000652
AC:
2
AN:
30677
American (AMR)
AF:
0.00
AC:
0
AN:
10526
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2647
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3577
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2711
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6022
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
240
European-Non Finnish (NFE)
AF:
0.0000376
AC:
2
AN:
53126
Other (OTH)
AF:
0.00
AC:
0
AN:
1495
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000214
Hom.:
1
Bravo
AF:
0.0000302

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

FG syndrome Uncertain:1
Jan 03, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change falls in intron 26 of the MED12 gene. It does not directly change the encoded amino acid sequence of the MED12 protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs373381746, gnomAD 0.01%), including at least one homozygous and/or hemizygous individual. This variant has not been reported in the literature in individuals affected with MED12-related conditions. ClinVar contains an entry for this variant (Variation ID: 408884). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

not specified Benign:1
Mar 06, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.58
CADD
Benign
8.0
DANN
Benign
0.88
PhyloP100
-1.5
PromoterAI
-0.022
Neutral
Mutation Taster
=87/13
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00024
dbscSNV1_RF
Benign
0.014
SpliceAI score (max)
0.090
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs373381746; hg19: chrX-70349283; API